Moleculin Biotech, Inc.
Q4 2024 13F Holders
Symbol
MBRX
CUSIP
60855D309
Type
Equity
Class
COM
Num filings
22
Total reported value, excl. options
$790 k
Compare 2024 Q4 to
2025 Q3
2025 Q2
2025 Q1
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type